APPH — Apontis Pharma AG Balance Sheet
0.000.00%
- €89.96m
- €78.59m
- €48.47m
- 68
- 20
- 75
- 54
Annual balance sheet for Apontis Pharma AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 8.06 | 29.8 | 36.3 | 26.8 | 15.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.47 | 3.02 | 2.44 | 1.2 | 0.231 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 12.9 | 38 | 42.4 | 35.1 | 22.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.041 | 0.019 | 0.045 | 0.03 | 0.018 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 29.7 | 54.1 | 59.9 | 57.5 | 44.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.31 | 3.68 | 5.96 | 11.3 | 5.12 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.2 | 13.4 | 18.3 | 27.2 | 13.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 3.46 | 40.7 | 41.6 | 30.3 | 31 |
| Total Liabilities & Shareholders' Equity | 29.7 | 54.1 | 59.9 | 57.5 | 44.4 |
| Total Common Shares Outstanding |